Menopausal hormones and risk of ovarian cancer
- 1 July 2005
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 193 (1) , 76-82
- https://doi.org/10.1016/j.ajog.2004.11.013
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated Diagnostic ProceduresThe Women's Health Initiative Randomized TrialJAMA, 2003
- Menopausal Hormone Replacement Therapy and Risk of Ovarian CancerJAMA, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Use of menopausal estrogens and medroxyprogesterone in the United States, 1982–1992Published by Wolters Kluwer Health ,2000
- Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studiesInternational Journal of Cancer, 1999
- Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? 1☆Journal of the Society for Gynecologic Investigation, 1998
- Hormone replacement therapy as a risk factor for epithelial ovarian cancer: Results of a case-control studyPublished by Wolters Kluwer Health ,1998
- Differences in Risk Factors for Epithelial Ovarian Cancer by Histologic Type: Results of a Case-Control StudyAmerican Journal of Epidemiology, 1996
- Association of Exogenous Estrogen and Endometrial CarcinomaNew England Journal of Medicine, 1975